Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer ; volume:10 ; number:1 ; day:23 ; month:11 ; year:2020 ; pages:1-12 ; date:12.2020
Scientific reports ; 10, Heft 1 (23.11.2020), 1-12, 12.2020
- Creator
-
Lee, Changhu
Ryu, Hyung Won
Kim, Sahee
Kim, Min
Oh, Sei-Ryang
Ahn, Kyung-Seop
Park, Jiyoung
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-77401-7
- URN
-
urn:nbn:de:101:1-2020122819060507641890
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Changhu
- Ryu, Hyung Won
- Kim, Sahee
- Kim, Min
- Oh, Sei-Ryang
- Ahn, Kyung-Seop
- Park, Jiyoung
- SpringerLink (Online service)
Other Objects (12)
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy